Depression Combination Therapy Using tES Neuromodulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for depression, particularly those involving pharmacological antidepressants, often fail to achieve significant symptom improvement in a large enough number of subjects, require prolonged treatment durations, and carry risks of adverse drug reactions and side effects.
Innovation Solution
Combining transcranial electrical stimulation (tES) with pharmacological antidepressant administration to deliver neuromodulation, allowing for improved symptom management and potential reduction in treatment duration and adverse effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If pharmacological antidepressants are administered alone, then treatment can be simple and well-tolerated, but symptom improvement is insufficient and treatment duration is prolonged
Solution Approach 1:
The patent combines transcranial electrical stimulation (tES) with pharmacological antidepressant administration to create a dual-action treatment approach. The tES device delivers electrical currents to specific brain regions while the patient simultaneously receives antidepressant medication, creating a synergistic effect that improves symptom remission rates compared to either treatment alone.
Solution Approach 2:
The treatment protocol creates a composite therapeutic approach by integrating two different treatment modalities: physical stimulation (tES) and chemical intervention (antidepressants). This composite strategy leverages the complementary mechanisms of action to achieve better clinical outcomes than monotherapy.
2Reliability
If prolonged treatment with antidepressants is used, then treatment effectiveness can be evaluated, but adverse drug reactions and side effects increase
Solution Approach 1:
The patent applies transcranial electrical stimulation as a preliminary or concurrent intervention to accelerate the therapeutic effect of antidepressants. By activating neural circuits beforehand or simultaneously with medication administration, the treatment achieves symptom improvement more rapidly, reducing the duration of exposure to potential side effects.
Solution Approach 2:
The combination therapy allows for optimization of antidepressant dosage parameters. By adding tES, the protocol can achieve therapeutic effects at lower medication doses or for shorter durations, thereby reducing the cumulative exposure to adverse drug reactions while maintaining treatment effectiveness.
3Reliability
If higher dosages or modified treatment regimens are used, then treatment effectiveness may improve, but treatment duration is prolonged and patient suffering increases
Solution Approach 1:
The patent employs continuous or repeated tES sessions in conjunction with antidepressant administration to maintain sustained therapeutic activation of neural circuits. This continuous stimulation approach accelerates the time course of symptom improvement, preventing treatment delays that would occur with dosage modifications alone.
Solution Approach 2:
The treatment protocol is dynamically adjusted by combining fixed antidepressant dosing with flexible tES parameters that can be optimized based on patient response. This dynamic approach allows for rapid titration to effective treatment levels without the delays associated with gradual dosage increases alone.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This combination results in more extensive symptom improvement, increased remission rates, and reduced adverse effects, enabling faster and sustained relief from depression symptoms.
Implementation Method 1
tES utilizes low intensity electrical stimulation of selected areas of the brain and has been demonstrated as a safe, efficient, and cost-effective means of inducing neuromodulation
Data Source
AI summary
Provided are methods for treating depression and depression-related conditions by combining administration of pharmacologic agents and neuromodulation induced by transcranial electrical stimulation.